Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy

NCT05137899 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Recruitment challenges, Hoffman La Roche strategic priority shift

Conditions

Hepatocellular Carcinoma
Portal Vein Tumour Thrombosis

Interventions

COMBINATION_PRODUCT: Neoadjuvant

Sponsor

Ontario Clinical Oncology Group (OCOG)

Collaborators

[object Object]